Literature DB >> 3510986

Plasmids coding for drug resistance and localized adherence to HeLa cells in enteropathogenic Escherichia coli O55:H- and O55:H6.

M Z Laporta, M L Silva, I C Scaletsky, L R Trabulsi.   

Abstract

Plasmids coding for drug resistance and localized adherence (LA) to HeLa cells were found in two enteropathogenic Escherichia coli strains belonging to serotypes O55:H- and O55:H6. Strain 49-81 HSJ (O55:H-) carries two plasmids, one coding for both ampicillin resistance (Apr) and LA (pMS49). Strain 71-82 HSJ (O55:H6) harbors only one plasmid, coding for resistance to sulfadiazine, chloramphenicol, kanamycin, ampicillin, and LA (pMS71). Plasmids pMS49 and pMS71 were transferred to E. coli K-12 711 and from this strain to E. coli K-12 J53. Curing with acridine orange of an Apr LA+ transconjugant showed that both characteristics were lost simultaneously. The plasmids have a molecular weight of approximately 55 X 10(6) and are the first naturally recombinant plasmids coding for adherence and drug resistance described in enteropathogenic E. coli.

Entities:  

Mesh:

Year:  1986        PMID: 3510986      PMCID: PMC262420          DOI: 10.1128/iai.51.2.715-717.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  A rapid alkaline extraction procedure for screening recombinant plasmid DNA.

Authors:  H C Birnboim; J Doly
Journal:  Nucleic Acids Res       Date:  1979-11-24       Impact factor: 16.971

2.  Naturally occurring plasmid carrying genes for enterotoxin production and drug resistance.

Authors:  C L Gyles; S Palchaudhuri; W K Maas
Journal:  Science       Date:  1977-10-14       Impact factor: 47.728

3.  Antibiotic susceptibility testing by a standardized single disk method.

Authors:  A W Bauer; W M Kirby; J C Sherris; M Turck
Journal:  Am J Clin Pathol       Date:  1966-04       Impact factor: 2.493

4.  Transfer of a CFA/I-ST plasmid promoted by a conjugative plasmid in a strain of Escherichia coli of serotype O128ac:H12.

Authors:  M H Reis; M Heloiza; T Affonso; L R Trabulsi; A J Mazaitis; R Maas; W K Maas
Journal:  Infect Immun       Date:  1980-07       Impact factor: 3.441

5.  Pathogenesis of escherichia coli gastroenteritis in man--another mechanism.

Authors:  M H Ulshen; J L Rollo
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

6.  A clinicopathologic study of enterocyte-adherent Escherichia coli: a cause of protracted diarrhea in infants.

Authors:  R Rothbaum; A J McAdams; R Giannella; J C Partin
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

7.  Enterotoxigenicity of enteropathogenic serotypes of Escherichia coli isolated from infants with epidemic diarrhea.

Authors:  F A Klipstein; B Rowe; R F Engert; H B Short; R J Gross
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Chronic diarrhea in infants caused by adherent enteropathogenic Escherichia coli.

Authors:  C R Clausen; D L Christie
Journal:  J Pediatr       Date:  1982-03       Impact factor: 4.406

10.  Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck; M R Thompson; S B Formal
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

View more
  11 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Characterization of plasmids encoding the adherence factor of enteropathogenic Escherichia coli.

Authors:  J P Nataro; K O Maher; P Mackie; J B Kaper
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

3.  Role of plasmid-encoded adherence factors in adhesion of enteropathogenic Escherichia coli to HEp-2 cells.

Authors:  S Knutton; M M Baldini; J B Kaper; A S McNeish
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

4.  Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains.

Authors:  T E Blank; H Zhong; A L Bell; T S Whittam; M S Donnenberg
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  Sources of variation in the ampicillin-resistant Escherichia coli concentration in the feces of organic broiler chickens.

Authors:  E J Pleydell; P E Brown; M J Woodward; R H Davies; N P French
Journal:  Appl Environ Microbiol       Date:  2006-11-03       Impact factor: 4.792

6.  Plasmid-encoded expression of lipopolysaccharide O-antigenic polysaccharide in enteropathogenic Escherichia coli.

Authors:  L W Riley; L N Junio; L B Libaek; G K Schoolnik
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

Review 7.  Adhesion and its role in the virulence of enteropathogenic Escherichia coli.

Authors:  D Law
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

8.  Colonization of neonates in a nursery ward with enteropathogenic Escherichia coli and correlation to the clinical histories of the children.

Authors:  D Senerwa; O Olsvik; L N Mutanda; J M Gathuma; K Wachsmuth
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

9.  Identification of plasmid-encoded mannose-resistant hemagglutinin and HEp-2 and HeLa cell adherence factors of two diarrheagenic Escherichia coli strains belonging to an enteropathogenic serogroup.

Authors:  R Pal; A C Ghose
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

10.  Cryptosporidium rhoptry effector protein ROP1 injected during invasion targets the host cytoskeletal modulator LMO7.

Authors:  Amandine Guérin; Nathan H Roy; Emily M Kugler; Laurence Berry; Janis K Burkhardt; Jung-Bum Shin; Boris Striepen
Journal:  Cell Host Microbe       Date:  2021-08-03       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.